Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
巴戟口服液 (Baji Oral Liquid) is a traditional Chinese medicine (TCM) oral liquid formulation developed and marketed by Chongqing Healn Pharmaceutical. The preparation is primarily derived from the root of *Morinda officinalis* (Bajitian), a well-known herb in traditional Chinese pharmacopoeia. It is traditionally used to tonify the kidney-yang, strengthen tendons and bones, and dispel wind-dampness. Clinical indications typically include symptoms associated with kidney-yang deficiency, such as sexual dysfunction (impotence, spermatorrhea), physical fatigue, and rheumatic aches. As a TCM product, its therapeutic effects are attributed to the synergistic action of various phytochemicals found in *Morinda officinalis*, including iridoid glycosides, oligosaccharides, and anthraquinones, although specific molecular targets for the finished formulation are not typically defined in standard pharmaceutical contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 巴戟口服液.